Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

What is an Important Change in the Short Physical Performance Battery (SPPB)?

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Royal Brompton & Harefield NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01649193
First received: July 9, 2012
Last updated: November 4, 2014
Last verified: November 2014
  Purpose

The purpose of this study is to determine the important change in the Short Physical Performance Battery (SPPB) when used in patients with lung disease. The SPPB is a simple physical test that measures balance and the functioning of the legs. It has been widely used in healthy elderly populations and predicts hospital admission and the onset of disability. The SPPB has not previously been used in patients with lung disease, and it is not clear what change in this test is considered meaningful and worthwhile by patients or doctors (the minimal clinically important difference: MID). Knowing what the MID for the SPPB will allow researchers and doctors to evaluate the effectiveness of current and new treatments, and to detect improvement or deterioration in the condition of patients.


Condition Intervention
Respiratory Tract Diseases
Lung Diseases
Other: Pulmonary rehabilitation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Determining the Minimal Important Difference of the Short Physical Performance Battery and 4m Gait Speed in Chronic Respiratory Disease Patients.

Resource links provided by NLM:


Further study details as provided by Royal Brompton & Harefield NHS Foundation Trust:

Primary Outcome Measures:
  • Change from baseline of Short Physical Performance Battery [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change from baseline of MRC Dyspnoea Scale [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
  • Change from baseline of St George's Respiratory Questionaire [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
  • Anchor question (5-point Likert scale) [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Blood taken and stored as whole blood, serum, and plasma.


Enrollment: 400
Study Start Date: March 2012
Study Completion Date: May 2014
Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Chronic Respiratory Disease
Any patient with a chronic respiratory disease referred for pulmonary rehabilitation
Other: Pulmonary rehabilitation
An eight week out-patient based programme consisting of twice weekly supervised exercise and educational sessions

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All chronic respiratory disease patients referred for pulmonary rehabilitation.

Criteria

Inclusion Criteria:

  • All patients entering pulmonary rehabilitation

Exclusion Criteria:

  • Any patient in whom mobility and lower limb function have been significantly affected by a neuromuscular cause, severe peripheral vascular disease or amputation.
  • Any patient whom the chief investigator feels it is unsafe to exercise (e.g. unstable cardiac disease).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01649193

Locations
United Kingdom
Harefield Hospital
Harefield, Middlesex, United Kingdom, UB9 6JH
Sponsors and Collaborators
Royal Brompton & Harefield NHS Foundation Trust
Investigators
Principal Investigator: William DC Man, MRCP, PhD Repiratory Biomedical Reserach Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College London
  More Information

Publications:
Responsible Party: Royal Brompton & Harefield NHS Foundation Trust
ClinicalTrials.gov Identifier: NCT01649193     History of Changes
Other Study ID Numbers: 2012LF001H
Study First Received: July 9, 2012
Last Updated: November 4, 2014
Health Authority: United Kingdom: National Institute for Health Research
United Kingdom: Research Ethics Committee
United Kingdom: Department of Health

Keywords provided by Royal Brompton & Harefield NHS Foundation Trust:
Rehabilitation [E02.831]
Exercise [G11.427.394.380]
Health Education [I02.233.332]
[C08]
[C08.381]

Additional relevant MeSH terms:
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on November 25, 2014